Summary

Myeloid neoplasms are a group of diseases in which the bone marrow produces an abnormal quantity of precursors for red blood cells, platelets or certain types of white blood cells. This leads to a variety of symptoms and from fatigue to bones fragility and, eventually, to a higher risk of developing Acute Myeloid Leukemia (AML).

Despite the advances produced during the last decades, not all those diagnosed benefit from efficient therapies. Advancing in the knowledge of myeloid neoplasms is, therefore, paramount to increase both prognosis and survival of patients.